Although it has been shown that the breast cancer-specific mortality was unrelated to E-cadherin expression in multiple models, E-cadherin low expression has been associated with lobular histology, tumor characteristics and menopausal hormone use, with no evidence of an association with breast cancer-specific survival. Here, CDH1 is linked to neoplasm.